Literature
Assessment of correlation of response to Drug-Eluting Bead doxorubicin (DEBDOX) in explanted liver in patients with HCC listed for orthoptic liver transplantations |
|
|---|---|
| Date | 28 September 2011 |
| Where presented | Asian Pacific HPBA 2011, Melbourne |
| Author(s) | Dr Andrew Holden |
| Resources | |
Five-year survival data of HCC patients treated with DC Bead at Athens Centre |
|
|---|---|
| Date | 12 September 2011 |
| Where presented | CIRSE 2011, Munich |
| Author(s) | Prof K Malagari |
| Resources | |
Five-year survival follow-up of 100 HCC patients treated with DC Bead at BCLC: a retrospective analysis |
|
|---|---|
| Date | 11 September 2011 |
| Where presented | CIRSE 2011, Munich |
| Author(s) | Dr Marta Burrel |
| Resources | |
Clinical results of phase II trial of sorafenib combined with Drug-Eluting Bead doxorubicin (DEBDOX) for patients with hepatocellular carcinoma |
|
|---|---|
| Date | 11 September 2011 |
| Where presented | CIRSE 2011, Munich |
| Author(s) | Prof Jeff Geschwind |
| Resources | |
Abstract: Early stage HCC: Update on recent trials |
|
|---|---|
| Date | 10 September 2011 |
| Where presented | CIRSE 2011, Munich |
| Author(s) | R Lencioni |
| Resources | |
Abstract: Early Stage HCC: How to ablate - current options |
|
|---|---|
| Date | 10 September 2011 |
| Where presented | CIRSE 2011, Munich |
| Author(s) | M Bezzi |
| Resources | |
Abstract: Early stage HCC: Segmental transcatheter approach to the early tumour |
|
|---|---|
| Date | 10 September 2011 |
| Where presented | CIRSE 2011, Munich |
| Author(s) | Y Arai |
| Resources | |
Abstract: Early stage HCC: Imaging and staging |
|
|---|---|
| Date | 10 September 2011 |
| Where presented | CIRSE 2011, Munich |
| Author(s) | D Brisbois |
| Resources | |
Asian Experience with Drug-Eluting beads for HCC and Rationale for the TRACER Study |
|
|---|---|
| Date | 3 September 2011 |
| Where presented | International Liver Cancer Association (ILCA) 2011 |
| Author(s) | Prof Ronnie Poon |
| Resources | |
Five-year follow up with DEBDOX in intermediate HCC, BCLC experience |
|
|---|---|
| Date | 3 September 2011 |
| Where presented | International Liver Cancer Association (ILCA) 2011, Hong Kong |
| Author(s) | Prof Jordi Bruix |
| Resources | |
Is DEBDOX the new standard for chemoembolisation? |
|
|---|---|
| Date | 3 September 2011 |
| Where presented | International Liver Cancer Association (ILCA) 2011 |
| Author(s) | Prof Riccardo Lencioni |
| Resources | |
Overview of HCC management and rationale for SPACE trial |
|
|---|---|
| Date | 3 September 2011 |
| Where presented | International Liver Cancer Association (ILCA) 2011, Hong Kong |
| Author(s) | Prof Josep Llovet |
| Resources | |
Doxorubicin Eluting Beads-Chemoembolization for Unresectable Hepatocellular Carcinoma in the Setting of Portal Vein Thrombosis: Midterm results (presentation synopsis) |
|
|---|---|
| Where presented | June 9 - 12, 2011, New York |
| Conference | World Conference on Interventional Oncology (WCIO) |
| Author(s) | A Zybulewski, J Weintraub, S Nowakowski et al |
| Resources | |
Hepatic Artery Occlusion Following Embolization with Bead Block vs LC Bead for HCC (presentation synopsis) |
|
|---|---|
| Where presented | June 9 - 12, 2011, New York |
| Conference | World Conference on Interventional Oncology (WCIO) |
| Author(s) | KT Brown, KN Johnson, GI Getrajdman et al |
| Resources | |
Is radiofrequency ablation still the standard of treatment for cirrhotic patients with HCC awaiting liver transplantation? (presentation synopsis) |
|
|---|---|
| Where presented | June 9 - 12, 2011, New York |
| Conference | World Conference on Interventional Oncology (WCIO) |
| Author(s) | A Nicolini, RM Lauro, L Martinetti et al |
| Resources | |
Liver and Biliary Injuries Following Transarterial Chemoembolization of Endocrine Tumors and Hepatocellular Carcinoma: Lipiodol versus Drug-Eluting Beads (presentation synopsis) |
|
|---|---|
| Where presented | June 9 - 12, 2011, New York |
| Conference | World Conference on Interventional Oncology (WCIO) |
| Author(s) | B Guiu, F Deschamps, S Aho et al |
| Resources | |
Transarterial embolization of hepatocellular carcinoma with doxorubicin-eluting beads: a single center experience (poster) |
|
|---|---|
| Where presented | June 9 -12, 2011, New York |
| Conference | World Conference on Interventional Oncology (WCIO) |
| Author(s) | T Fredenburg, J Ramkaransingh - Indiana University, Indianapolis |
| Resources | |
Comparative study between DC Bead loaded with doxorubicin and conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma in Korea (abstract) |
|
|---|---|
| Where presented | March 30 - April 3 2011, Berlin, Germany |
| Conference | European Association for the Study of the Liver (EASL) |
| Author(s) | M Song, C-H Park, P Sung et al |
| Resources | |
Final results of a prospective randomized trial assessing survival at 2 years of DEBIRI vs FOLFIRI in patients with hepatic metastases from colorectal cancer (symposium presentation - Drug-Eluting Beads: Survival Data) |
|
|---|---|
| Where presented | 27 - 30 April, 2011 |
| Conference | Global Embolization Symposium and Technologies (GEST) |
| Author(s) | G Fiorentini |
| Resources | |
4 years survival of 100 HCC patients treated with DC Bead: a retrospective analysis (symposium presentation - Drug-Eluting Beads: Survival Data) |
|
|---|---|
| Where presented | 27 - 30 April 2011, Paris, France |
| Conference | Global Embolization Symposium and Technologies (GEST) |
| Author(s) | M Burrel |
| Resources | |